Previous studies indicate that the gain-of-function mutation (i.e. KCNA5) and the abnormally elevated expression level (i.e. PITX2) can contribute to the initiation and maintenance of AF (Christophersen et al., 2013; Syeda et al., 2016). The gene discussed is PITX2; the disease is atrial fibrillation.